Compare
DNA X, Inc. vs FiEE, Inc. vs Clearfield, Inc. vs Clearone Inc
| Latest fiscal year | DNA X, Inc. SONM | FiEE, Inc. FIEE | Clearfield, Inc. CLFD | Clearone Inc CLRO |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-09-30 | 2025-12-31 |
| Revenue | n/a | $6.19M | $150.13M | $0 |
| Revenue growth (YoY) | n/a | +867.9% | +19.6% | n/a |
| Gross margin | n/a | 86.4% | 33.7% | n/a |
| Operating margin | n/a | 25.0% | 1.4% | n/a |
| Net margin | n/a | 17.3% | -5.4% | n/a |
| Net income | -$20.66M | $1.07M | -$8.05M | -$26.08M |
| EPS (Diluted) | -$28.58 | $0.10 | -$0.58 | -$14.77 |
| Operating cash flow | -$23.53M | $3.64M | $26.55M | -$14.55M |
| Free cash flow | n/a | $3.45M | $21.81M | n/a |
| Cash & equivalents | $1.30M | $3.08M | $21.49M | $220.0K |
| Total assets | $43.90M | $10.77M | $306.17M | $2.30M |
| Total liabilities | $50.62M | $4.18M | $50.01M | $3.01M |
| Shareholders' equity | -$7.96M | $6.59M | $256.16M | -$714.0K |
| Return on year-end equity | n/a | 16.3% | -3.1% | n/a |
| Shares outstanding | 1.27M | 7.93M | 13.84M | 2.24M |
Revenue, most recent five fiscal years
| Fiscal year | DNA X, Inc. | FiEE, Inc. | Clearfield, Inc. | Clearone Inc |
|---|---|---|---|---|
| Latest | $58.30M Ended 2024-12-31 | $6.19M Ended 2025-12-31 | $150.13M Ended 2025-09-30 | $0 Ended 2025-12-31 |
| 1 year earlier | $93.63M Ended 2023-12-31 | $639.9K Ended 2024-12-31 | $125.57M Ended 2024-09-30 | $0 Ended 2024-12-31 |
| 2 years earlier | $69.83M Ended 2022-12-31 | $26.11M Ended 2023-12-31 | $225.72M Ended 2023-09-30 | $18.70M Ended 2023-12-31 |
| 3 years earlier | $54.57M Ended 2021-12-31 | $50.62M Ended 2022-12-31 | $270.88M Ended 2022-09-30 | $25.20M Ended 2022-12-31 |
| 4 years earlier | $63.99M Ended 2020-12-31 | $55.42M Ended 2021-12-31 | $140.75M Ended 2021-09-30 | $28.97M Ended 2021-12-31 |